HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Georg Schett Selected Research

Lipids

1/2023Non-invasive metabolic profiling of inflammation in joints and entheses by multispectral optoacoustic tomography.
10/2020Formation of atherosclerotic lesions is independent of eosinophils in male mice.
11/2019Resolution of inflammation in arthritis.
7/2017Enzymatic lipid oxidation by eosinophils propagates coagulation, hemostasis, and thrombotic disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Georg Schett Research Topics

Disease

127Inflammation (Inflammations)
02/2024 - 03/2002
110Rheumatoid Arthritis
04/2024 - 11/2002
104Arthritis (Polyarthritis)
03/2024 - 01/2003
71Fibrosis (Cirrhosis)
03/2024 - 01/2007
50Psoriatic Arthritis
03/2024 - 10/2010
46Systemic Scleroderma (Systemic Sclerosis)
03/2024 - 01/2007
26Psoriasis (Pustulosis Palmaris et Plantaris)
03/2024 - 10/2010
26Necrosis
01/2023 - 01/2005
25Autoimmune Diseases (Autoimmune Disease)
03/2024 - 02/2006
25Bone Resorption
01/2022 - 07/2003
21Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2024 - 02/2006
19COVID-19
12/2023 - 01/2020
18Neoplasms (Cancer)
02/2024 - 05/2011
18Rheumatic Diseases (Rheumatism)
12/2023 - 05/2008
18Osteoarthritis
01/2023 - 07/2010
15Experimental Arthritis
02/2024 - 05/2005
15Joint Diseases (Joint Disease)
01/2023 - 07/2007
14Infections
12/2023 - 05/2012
13Synovitis
04/2024 - 01/2008
13Pain (Aches)
03/2024 - 03/2011
13Gout
09/2021 - 04/2010
11Bronchiolitis Obliterans Syndrome
03/2024 - 10/2012
9Osteoporosis
02/2022 - 07/2004
8Osteophyte
01/2022 - 07/2013
8Atherosclerosis
10/2020 - 05/2004
7Pulmonary Fibrosis (Fibrosing Alveolitis)
03/2024 - 08/2008
7Osteitis
02/2024 - 01/2004
7Ankylosing Spondylitis
12/2023 - 07/2009
7Vascular Diseases (Vascular Disease)
01/2020 - 12/2005
6Vasculitis (Vasculitides)
01/2023 - 11/2010
6Postmenopausal Osteoporosis
02/2022 - 08/2010
6Hypoxia (Hypoxemia)
01/2022 - 12/2007
6Churg-Strauss Syndrome (Allergic Angiitis)
11/2019 - 02/2009
5Disease Progression
06/2024 - 05/2016
5Skin Diseases (Skin Disease)
01/2023 - 04/2015
5Cardiovascular Diseases (Cardiovascular Disease)
01/2018 - 05/2004
4Melanoma (Melanoma, Malignant)
04/2024 - 01/2014

Drug/Important Bio-Agent (IBA)

60CytokinesIBA
03/2024 - 11/2002
46Bleomycin (Blenoxane)FDA LinkGeneric
03/2024 - 01/2007
44Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2024 - 03/2002
43Proteins (Proteins, Gene)FDA Link
02/2024 - 01/2007
40AutoantibodiesIBA
04/2024 - 12/2005
33AntibodiesIBA
12/2023 - 02/2006
27CollagenIBA
01/2023 - 10/2005
26Biomarkers (Surrogate Marker)IBA
02/2024 - 10/2005
25Antirheumatic Agents (DMARD)IBA
03/2024 - 06/2005
24Immunoglobulin G (IgG)IBA
08/2023 - 12/2005
17LigandsIBA
03/2024 - 11/2006
17InterleukinsIBA
03/2024 - 02/2012
17Uric Acid (Urate)IBA
01/2023 - 04/2010
16Interleukin-17 (Interleukin 17)IBA
03/2024 - 02/2012
15Transforming Growth Factors (Transforming Growth Factor)IBA
03/2024 - 05/2012
14Methotrexate (Mexate)FDA LinkGeneric
03/2024 - 09/2011
14indium-bleomycinIBA
01/2018 - 12/2011
13RNA (Ribonucleic Acid)IBA
04/2024 - 01/2017
12AntigensIBA
01/2022 - 05/2008
12Transcription Factors (Transcription Factor)IBA
01/2022 - 12/2009
12OsteoprotegerinIBA
01/2018 - 03/2002
11EnzymesIBA
01/2022 - 11/2010
10Interleukin-1 (Interleukin 1)IBA
12/2023 - 12/2003
10secukinumabIBA
12/2023 - 01/2018
10Monoclonal AntibodiesIBA
11/2023 - 06/2008
10GlucocorticoidsIBA
12/2022 - 03/2013
10Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2015
10apremilastIBA
08/2020 - 10/2010
10Hydroxyproline (4 Hydroxyproline)IBA
03/2016 - 11/2010
9ChemokinesIBA
04/2024 - 11/2010
9guselkumabIBA
03/2024 - 11/2021
9Immunoglobulin A (IgA)IBA
01/2024 - 03/2012
9Tumor Necrosis Factor InhibitorsIBA
01/2024 - 05/2005
9AutoantigensIBA
01/2023 - 12/2005
9DNA (Deoxyribonucleic Acid)IBA
10/2022 - 02/2006
9tocilizumab (atlizumab)FDA Link
01/2019 - 05/2012
8C-Reactive ProteinIBA
10/2022 - 12/2006
7Chimeric Antigen ReceptorsIBA
06/2024 - 10/2022
7Interleukin-23 (Interleukin 23)IBA
01/2024 - 09/2015
7Histones (Histone)IBA
12/2022 - 01/2012
7Messenger RNA (mRNA)IBA
06/2022 - 04/2011
6Phosphotransferases (Kinase)IBA
01/2024 - 07/2008
6Rituximab (Mabthera)FDA Link
11/2023 - 05/2012
6baricitinibIBA
11/2023 - 09/2018
6Rheumatoid FactorIBA
10/2022 - 03/2014
6Transcription Factor AP-1 (Transcription Factor AP 1)IBA
01/2021 - 12/2009
6Cathepsin KIBA
01/2016 - 10/2005
5Peptides (Polypeptides)IBA
03/2024 - 12/2005
5Small Interfering RNA (siRNA)IBA
01/2024 - 05/2012
5Glucose (Dextrose)FDA LinkGeneric
05/2022 - 03/2013
5Estrogens (Estrogen)FDA Link
02/2022 - 03/2013
5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 05/2009
5OsteocalcinIBA
08/2021 - 01/2006
5RANK LigandIBA
06/2013 - 10/2005
5Imatinib Mesylate (Gleevec)FDA Link
11/2012 - 01/2007
4Immunomodulating AgentsIBA
05/2024 - 05/2021
4Acute-Phase Proteins (Acute-Phase Protein)IBA
04/2024 - 01/2009
4ametantrone (HAQ)IBA
03/2024 - 04/2013
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2024 - 10/2008
4acetyl 4-aminosalicylic acidIBA
02/2024 - 08/2014
4VaccinesIBA
08/2023 - 10/2021

Therapy/Procedure

89Therapeutics
06/2024 - 03/2002
8Ovariectomy (Oophorectomy)
02/2022 - 08/2010